ARID1A and cholangiocarcinoma: As shown in Table 3, ARID1A mutations tended to associate with CCA staging (p = 0.041, adjusted p-value = 0.137), liver fluke related-CCA (p = 0.010, adjusted p-value = 0.085), and T factor (p = 0.017, adjusted p-value = 0.085).